Developer docs
API playgroundTry for free, no card

Search company profiles

ZEINCRO Group

Full company profile

uuid000ex8x

Namestring
ZEINCRO Group
Websiteurl
zeincro.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

ZEINCRO Group is a privately held contract research organisation (CRO) headquartered in Sofia, Bulgaria, that provides clinical research services with a regional focus on Central and South-Eastern Europe. The company was founded in 1998 and currently operates with a headcount in the 101-250 range, placing it in the mid-sized tier of European CROs. Its self-described positioning is that of a regional specialist, suggesting it serves pharmaceutical and biotechnology sponsors running clinical trials that require country coverage, investigator networks, and regulatory navigation across multiple CEE jurisdictions rather than as a global full-service provider.

The company's core offering falls within the clinical research services value chain, which typically includes clinical trial management, site monitoring, regulatory affairs, pharmacovigilance, and biometrics support for sponsor-led studies. Specific service lines, therapeutic area depth, technology platforms, and proprietary tooling are not described in the available source data, and the company's own web property currently resolves to a cPanel default hosting error page, limiting the ability to verify current product detail. There is no information in the source material regarding its technology stack, electronic data capture systems, or any differentiated operating methodology.

ZEINCRO's revenue mechanics are likewise not disclosed in the source data; pricing model, contract structures (e.g., FTE-based, fee-for-service, milestone-based), customer segmentation (large pharma vs. mid-cap biotech vs. academic sponsors), and go-to-market approach are all unspecified. The firm has no recorded funding rounds, M&A activity, leadership changes, partnerships, or compliance certifications in the available data. The company's contact details indicate a generic webmaster channel (webmaster@zeincro.com) rather than a commercial contact, and no named customers, awards, or industry recognitions are documented. Given the data limitations, any assessment of ZEINCRO's current commercial performance must rely on industry benchmarks rather than primary disclosure.

Short descriptiontext

ZEINCRO Group is a Bulgaria-based contract research organisation, founded in 1998, that provides clinical research services to pharmaceutical and biotech sponsors with a regional focus on Central and South-Eastern Europe.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSofia, Bulgaria
HQ citystring
Sofia
HQ countrystring
Bulgaria
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
contract research, clinical trials, pharmaceutical services, medical research, biotech services
Industry1 code
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Services
Social media profiles1 record
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ZEINCRO is a contract research organisation (CRO) specialising in clinical research services across Central and South-Eastern Europe. The company delivers outsourced clinical research operations to pharmaceutical, biotechnology, and medical device sponsors operating in the region.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Contract Research Organisation Services
CategoryContract Research Services
No data
Peers10 records
TypeDirect peer
Description

Worldwide Clinical Trials is a mid-sized global CRO with deep European operations covering Phase II-IV across multiple therapeutic areas. Comparable to ZEINCRO as a mid-tier clinical CRO with European regional strength.

TypeBroad incumbent
Description

Parexel is a large global CRO with significant European clinical operations and a strong presence in CEE countries for Phase II-IV trials. Comparable to ZEINCRO in the clinical CRO service category serving biopharma sponsors across multiple therapeutic areas.

TypeBroad incumbent
Description

Clario is a clinical trial technology and endpoint services company with deep European trial operations post its merger of Bioclinica, ERT, and Merge. Comparable to ZEINCRO as a clinical-trial services provider with European delivery capabilities, particularly on technology-enabled study execution.

TypeBroad incumbent
Description

IQVIA is the largest global CRO and clinical technology provider, with established operations across the CEE region. Comparable to ZEINCRO as the dominant incumbent clinical CRO whose regional trial delivery capabilities overlap with ZEINCRO's specialized footprint.

TypeBroad incumbent
Description

Syneos Health is a leading global clinical CRO (now publicly taken private) with European clinical operations. Comparable to ZEINCRO in the clinical CRO service category serving biopharma sponsors across multiple countries.

TypeDirect peer
Description

Founded in Ukraine and now headquartered globally, PSI is a mid-sized clinical CRO with strong roots in the Central and Eastern European region. It is directly comparable to ZEINCRO as another regionally rooted CRO offering Phase I-IV clinical trial services across CEE and beyond.

TypeDirect peer
Description

Medpace is a U.S.-headquartered, mid-to-large clinical CRO with established European operations and a science-led operating model. Comparable to ZEINCRO in the clinical CRO service category and as a peer on mid-sized sponsor contracts using European sites.

TypeBroad incumbent
Description

Labcorp Drug Development is a large global CRO with central lab and clinical trial services across Europe. Comparable to ZEINCRO as a full-service clinical CRO with multi-country European trial delivery capabilities, though significantly larger and more diversified.

TypeDirect peer
Description

Ergomed was a mid-sized clinical CRO with specialty therapeutic expertise (notably oncology and rare disease) and a strong European footprint. ZEINCRO's regional European clinical CRO profile makes Ergomed a closely comparable mid-tier specialist peer.

TypeBroad incumbent
Description

ICON is one of the largest global CROs post its PRA Health Sciences merger, with extensive Eastern European site networks. Comparable to ZEINCRO as a clinical CRO competing for sponsor trials across European geographies, though at vastly greater scale.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ZEINCRO Group

Contract Research Serviceszeincro.com

ZEINCRO Group is a Bulgaria-based contract research organisation, founded in 1998, that provides clinical research services to pharmaceutical and biotech sponsors with a regional focus on Central and South-Eastern Europe.

What ZEINCRO Group does

ZEINCRO Group is a privately held contract research organisation (CRO) headquartered in Sofia, Bulgaria, that provides clinical research services with a regional focus on Central and South-Eastern Europe. The company was founded in 1998 and currently operates with a headcount in the 101-250 range, placing it in the mid-sized tier of European CROs. Its self-described positioning is that of a regional specialist, suggesting it serves pharmaceutical and biotechnology sponsors running clinical trials that require country coverage, investigator networks, and regulatory navigation across multiple CEE jurisdictions rather than as a global full-service provider.

The company's core offering falls within the clinical research services value chain, which typically includes clinical trial management, site monitoring, regulatory affairs, pharmacovigilance, and biometrics support for sponsor-led studies. Specific service lines, therapeutic area depth, technology platforms, and proprietary tooling are not described in the available source data, and the company's own web property currently resolves to a cPanel default hosting error page, limiting the ability to verify current product detail. There is no information in the source material regarding its technology stack, electronic data capture systems, or any differentiated operating methodology.

ZEINCRO's revenue mechanics are likewise not disclosed in the source data; pricing model, contract structures (e.g., FTE-based, fee-for-service, milestone-based), customer segmentation (large pharma vs. mid-cap biotech vs. academic sponsors), and go-to-market approach are all unspecified. The firm has no recorded funding rounds, M&A activity, leadership changes, partnerships, or compliance certifications in the available data. The company's contact details indicate a generic webmaster channel (webmaster@zeincro.com) rather than a commercial contact, and no named customers, awards, or industry recognitions are documented. Given the data limitations, any assessment of ZEINCRO's current commercial performance must rely on industry benchmarks rather than primary disclosure.

ZEINCRO Group firmographics

Firmographics
Name
ZEINCRO Group
Website
https://zeincro.com
Company type
Private
Founded year
1998
Headcount range
101–250 employees
Short description
ZEINCRO Group is a Bulgaria-based contract research organisation, founded in 1998, that provides clinical research services to pharmaceutical and biotech sponsors with a regional focus on Central and South-Eastern Europe.
Ownership category
akta.pro rank

ZEINCRO Group industry classification

Industry
Product category
Contract Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)

Keywords

  • Contract research
  • Clinical trials
  • Pharmaceutical services
  • Medical research
  • Biotech services

Where ZEINCRO Group is headquartered

Location

Headquarters

HQ city
Sofia
HQ country
Bulgaria
HQ region
Europe

Markets served

ZEINCRO Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

ZEINCRO Group product offering

Product offering

Core offering

ZEINCRO is a contract research organisation (CRO) specialising in clinical research services across Central and South-Eastern Europe. The company delivers outsourced clinical research operations to pharmaceutical, biotechnology, and medical device sponsors operating in the region.

Differentiator

Problem solved

Functional benefit

Products and services

  • Contract Research Organisation Services

Companies that use ZEINCRO Group

Customer profile

Ideal customer profiles1 record

ZEINCRO Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ZEINCRO Group competitors and assessment

Company assessment

Direct peers

  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with deep European operations covering Phase II-IV across multiple therapeutic areas. Comparable to ZEINCRO as a mid-tier clinical CRO with European regional strength.
  • PSI CRO: Founded in Ukraine and now headquartered globally, PSI is a mid-sized clinical CRO with strong roots in the Central and Eastern European region. It is directly comparable to ZEINCRO as another regionally rooted CRO offering Phase I-IV clinical trial services across CEE and beyond.
  • Medpace: Medpace is a U.S.-headquartered, mid-to-large clinical CRO with established European operations and a science-led operating model. Comparable to ZEINCRO in the clinical CRO service category and as a peer on mid-sized sponsor contracts using European sites.
  • Ergomed (now part of Clinipace Worldwide / acquired by Anglo-African): Ergomed was a mid-sized clinical CRO with specialty therapeutic expertise (notably oncology and rare disease) and a strong European footprint. ZEINCRO's regional European clinical CRO profile makes Ergomed a closely comparable mid-tier specialist peer.

Broad incumbents

  • Parexel International: Parexel is a large global CRO with significant European clinical operations and a strong presence in CEE countries for Phase II-IV trials. Comparable to ZEINCRO in the clinical CRO service category serving biopharma sponsors across multiple therapeutic areas.
  • Clario: Clario is a clinical trial technology and endpoint services company with deep European trial operations post its merger of Bioclinica, ERT, and Merge. Comparable to ZEINCRO as a clinical-trial services provider with European delivery capabilities, particularly on technology-enabled study execution.
  • IQVIA: IQVIA is the largest global CRO and clinical technology provider, with established operations across the CEE region. Comparable to ZEINCRO as the dominant incumbent clinical CRO whose regional trial delivery capabilities overlap with ZEINCRO's specialized footprint.
  • Syneos Health: Syneos Health is a leading global clinical CRO (now publicly taken private) with European clinical operations. Comparable to ZEINCRO in the clinical CRO service category serving biopharma sponsors across multiple countries.
  • Labcorp Drug Development (formerly Covance): Labcorp Drug Development is a large global CRO with central lab and clinical trial services across Europe. Comparable to ZEINCRO as a full-service clinical CRO with multi-country European trial delivery capabilities, though significantly larger and more diversified.
  • ICON plc: ICON is one of the largest global CROs post its PRA Health Sciences merger, with extensive Eastern European site networks. Comparable to ZEINCRO as a clinical CRO competing for sponsor trials across European geographies, though at vastly greater scale.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

ZEINCRO Group social profiles

Digital presence

ZEINCRO Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ZEINCRO Group leadership team

Management profile

Number of profiles

ZEINCRO Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ZEINCRO Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZEINCRO Group

What does ZEINCRO Group do?

ZEINCRO is a contract research organisation (CRO) specialising in clinical research services across Central and South-Eastern Europe. The company delivers outsourced clinical research operations to pharmaceutical, biotechnology, and medical device sponsors operating in the region.

When was ZEINCRO Group founded?

ZEINCRO Group was founded in 1998. It employs 101 to 250 people.

Where is ZEINCRO Group based?

ZEINCRO Group is headquartered in Sofia, Bulgaria, in the Europe region.

Who are ZEINCRO Group's main competitors?

Direct peers on record are Worldwide Clinical Trials, PSI CRO, Medpace and Ergomed (now part of Clinipace Worldwide / acquired by Anglo-African). Broad incumbents are Parexel International, Clario, IQVIA, Syneos Health, Labcorp Drug Development (formerly Covance) and ICON plc.

Does ZEINCRO Group have an API?

No public API is recorded for ZEINCRO Group.

What industry is ZEINCRO Group in?

ZEINCRO Group's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales